Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
753 stories · page 1 of 8
Mid-morning markets: Budget day nerves, GSK and Hunting disappoint and Asia's chip stocks surge
London cautious ahead of Healey's maiden Budget as a clutch of Footsie names report mixed numbers
FIVE AT FIVE: Musk floats a $3.5 trillion merger, GSK lands an FDA first and Ashtead agrees a £505 million exit
SpaceX and Tesla as one company, a hepatitis B breakthrough and London recovering its nerve
Archive
FTSE 100 struggles for direction; US inflation ahead of expectations
The FTSE 100 gave up earlier gains to trade below the mark on Thursday